Back to search
Prevention of Stroke or Systemic Embolism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Stroke or Systemic Embolism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Stroke or Systemic Embolism trials you may qualify for* To compare and evaluate the oral bioavailability of Edoxaban 60 mg Film Coated Tablet with that of Lixiana® 60 mg filmtabletten (Film Coated Tablet (Edoxaban)…
Researchers are looking for a better way to treat people with atrial fibrillation (AF) and prevent stroke or systemic embolism (blood clots travelling through t…
To characterize and analyze the number, type and incidence of adverse events/suspected adverse drug reactions in patients treated with Apixaban, according to th…
This is a retrospective observational study to describe the sociodemographic and clinical characteristics of patients diagnosed with non-valvular atrial fibrill…
describe the sociodemographic and clinical characteristics of patients diagnosed with non-valvular atrial fibrillation (NVAF) at risk of stroke or systemic embo…
This is a prospective and open label study that aims to enroll approximately 1200 patients with non-valvular atrial fibrillation (NVAF) not previously treated w…